Sunitinib malate for the treatment of pancreas malignancies-where does it fit? Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Indoles
  • Pancreatic Neoplasms
  • Pyrroles

abstract

  • Sunitinib malate has become integrated into routine clinical management for pNETs; however, its role in pancreas adenocarcinoma is not established.

publication date

  • April 2013

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1517/14656566.2013.776540

PubMed ID

  • 23458511

Additional Document Info

start page

  • 783

end page

  • 92

volume

  • 14

number

  • 6